The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Yen Kristen since 2023.
This trader's CIK number is 1643441.
At the time of last reporting, Yen Kristen was the SEE REMARKS of Soleno Therapeutics Inc. (stock ticker symbol SLNO).
Also see all insider trading activities at Soleno Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | SLNO | 0 | $0 | 100,360 | $6,785,353 | 40,638 | $172,833 |
| 2024 | SLNO | 0 | $0 | 29,175 | $1,342,953 | 0 | $0 |
| 2023 | SLNO | 0 | $0 | 49,442 | $1,734,597 | 17,916 | $44,843 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-27 | SLNO | Option Ex | 40,638 | 4.25 | 172,833 |
| 2025-03-27 | SLNO | Sale | 95,500 | 68.72 | 6,562,282 |
| 2025-01-02 | SLNO | Sale | 2,520 | 45.64 | 115,020 |
| 2025-01-03 | SLNO | Sale | 2,340 | 46.18 | 108,051 |
| 2024-10-01 | SLNO | Sale | 3,108 | 49.79 | 154,753 |
| 2024-08-28 | SLNO | Sale | 5,270 | 47.61 | 250,904 |
| 2024-08-29 | SLNO | Sale | 5,435 | 47.50 | 258,140 |
| 2024-08-05 | SLNO | Sale | 5,017 | 45.81 | 229,828 |
| 2024-08-06 | SLNO | Sale | 5,957 | 44.93 | 267,624 |
| 2024-07-01 | SLNO | Sale | 2,170 | 41.42 | 89,890 |
| 2024-04-01 | SLNO | Sale | 2,218 | 41.40 | 91,814 |
| 2023-12-13 | SLNO | Option Ex | 17,916 | 2.50 | 44,843 |
| 2023-12-12 | SLNO | Sale | 19,913 | 36.83 | 733,435 |
| 2023-12-13 | SLNO | Sale | 17,916 | 37.76 | 676,561 |
| 2023-11-30 | SLNO | Sale | 3,963 | 28.65 | 113,547 |
| 2023-11-29 | SLNO | Sale | 3,979 | 27.85 | 110,799 |
| 2023-11-28 | SLNO | Sale | 3,671 | 27.31 | 100,255 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yen Kristen (SEE REMARKS of Soleno Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.